High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome

Angiology

Volumn 63, Issue 6, 2012, Pages 448-452

  Duran, Mustafa ^a   Kalay, Nihat ^b   Akpek, Mahmut ^b   Orscelik, Ozcan ^b   Elcik, Deniz ^b   Ocak, Ayse ^b   Inanc, Mehmet Tugrul ^b   Kasapkara, H Ahmet ^c   Oguzhan, Abdurrahman ^b   Eryol, Namik K ^b   Ergin, Ali ^b   Kaya, Mehmet Gungor ^b  

^a Kayseri Education and Research Hospital ^*  (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

acute coronary syndrome; Gensini score; serum uric acid

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM; TRIACYLGLYCEROL; URIC ACID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL OCCLUSION; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERURICEMIA; LEUKOCYTE; MALE; POTASSIUM BLOOD LEVEL; RISK FACTOR; SODIUM BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY DISEASE; FEMALE; HUMANS; HYPERURICEMIA; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TURKEY; URIC ACID;

EID: 84859798199     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711426868     Document Type: Article

References (35)

1. Okura T, Higaki J, Kurata M, et al. Japanese coronary artery disease study investigators. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J. 2009;73(5):885-891.
2. Meisinger C, Koenig W, Baumert J, Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population. The MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol. 2008;28(6):1186-1192.
3. Karagiannis A, Mikhailidis DP, Tziomalos K, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J. 2007;71(7):1120-1127. (Pubitemid 46998030)
4. Høieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004;65(3):1041-1049. (Pubitemid 38251080)
5. Vasquez-Vivar J, Santos AM, Junqueira VB, Augusto O. Peroxynitrite- mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acid-derived free radicals. Biochem J. 1996;314(pt 3):869-876. (Pubitemid 26097749)
6. Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJ. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart. 1997;78(1):39-43. (Pubitemid 27346879)
7. Naghavi M, John R, Naguib S, et al. pH heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis. 2002;164(1):27-35. (Pubitemid 34765634)
8. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67(5):1739-1742. (Pubitemid 40577708)
9. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606-607.
10. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287-1293. (Pubitemid 36706079)
11. Krishnan E, Pandya BJ, Chung L, Dabbous O. Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study. Arthritis Res Ther. 2011;13(2):R66.
12. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009;61(2):225-232.
13. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. 2010;62(2):170-180.
14. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SR. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart. 2004;90(2):155-159. (Pubitemid 38147148)
15. Tsai TH, Chen YL, Chen SM, et al. Uric acid is not an independent predictor of cardiovascular death in patients with angiographically proven coronary artery disease. Chang Gung Med J. 2009;32(6):605-613.
16. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis. 2009;202(1):11-17.
17. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25(1):39-42. (Pubitemid 40128147)
18. Johnson R, Kang D, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183-1189.
19. Kanbay M, Sánchez-Losada LG, Franco M, et al. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant. 2011;26(2):430-437.
20. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol. 2006;62(6):633-644. (Pubitemid 44754682)
21. Tavil Y, Kaya MG, Oktar SO, et al. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis. 2008;197:159-163. (Pubitemid 351273235)
22. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811-1821.
23. Niskanen L, Laaksonen DE, Lindstrom J, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish diabetes prevention study. Diabetes Care. 2006;29(3):709-711. (Pubitemid 44115381)
24. Deveci OS, Kabakci G, Okutucu S, et al. The association between serum uric acid level and coronary artery disease. Int J Clin Pract. 2010;64(7):900-907.
25. Kanbay M, Ikizek M, Solak Y, et al. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol. 2011;33(4):325-331.
26. Lu P, Hu D, Lu J, Wang W, Chen B. The association between uric acid and coronary heart disease. Zhonghua Nei Ke Za Zhi. 2002;41(8):526-529.
27. Gur M, Yilmaz R, Demirbag R, Aksoy N. Relation of serum uric acid levels with the presence and severity of angiographic coronary artery disease. Angiology. 2008;59(2):166-171. (Pubitemid 351521110)
28. Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M. Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. Curr Pharm Des. 2005;11(32):4161-4175. (Pubitemid 41679180)
29. Jelic-Ivanic Z, Memon L, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Spasic S. Independent association of high serum uric acid concentration with angiographically defined coronary artery disease. Tohoku J Exp Med. 2007;211(4):369-377. (Pubitemid 46585550)
30. Vaziri ND, Freel RK, Hatch M. Effect of chronic experimental renal insufficiency on urate metabolism. J Am Soc Nephrol. 1995;6(4):1313-1317.
31. Athyros VG, Karagiannis A, Ganotakis ES, et al. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin. 2011;27(8):1659-1668.
32. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): a relationship with implications for vascular risk? Curr Vasc Pharmacol. 2011 Sep 22;9(6):698-705.
33. Strasak A, Ruttmann E, Brant L, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008;54(2):273-284. (Pubitemid 351302628)
34. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the syntax study. EuroIntervention. 2009;5(1):50-56.
35. AthyrosVG, Mikhailidis DP, LiberopoulosEN, et al. Effect of statin treatment on renal function and serumuric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of theGREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant. 2007;22(1):118-127. (Pubitemid 46050336)